Acceptability of the Human Papillomavirus Vaccine Among Urban Adolescent Males

Gutierrez, Baudelio; Leung, Anthony W.; Jones, Kevin Trimell; Smith, Peter; Silverman, Randee; Frank, Ian; Leader, Amy

doi:10.1177/1557988312456697

Cited by 37 publications

(44 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The majority of participants were white, either in education or already holding a higher degree, and living in urban areas. Participants were aged between 16 and 71 years, three studies targeted MSM below the age of 26 33 36 39. Participants were mainly recruited via convenience sampling within large urban areas: gay community events and meeting points (7), sexual health clinics (4), universities (3) and population-based panels (2).…”

Section: Resultsmentioning

confidence: 99%

“…Two studies reported that MSM believed HPV vaccination would be good, safe, smart, easy, important and harmless 33 39. In general, MSM considered the HPV vaccine effective in preventing HPV-related diseases, with one study indicating lower perceived effectiveness in preventing genital warts than cancers 40.…”

Section: Resultsmentioning

confidence: 99%

“…In general, MSM considered the HPV vaccine effective in preventing HPV-related diseases, with one study indicating lower perceived effectiveness in preventing genital warts than cancers 40. One study showed that young MSM believed they would be generally encouraged by their family and friends to be vaccinated 39. Five studies showed that MSM were concerned about high vaccine costs and possible side effects 28–30 33 40.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review

et al. 2014

View full text Add to dashboard Cite

Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital warts among men who have sex with men (MSM). In order to develop effective vaccination programmes for MSM, it is crucial to understand their knowledge, beliefs about HPV and attitudes towards HPV vaccine. Methods A systematic search of 10 databases examined articles investigating HPV knowledge and HPV-related perceptions among MSM. Each paper was assessed to identify potential research directions in the context of targeted HPV vaccination for MSM. Results We identified 16 studies that included 5185 MSM and conducted mainly in North America. Generally, participants were over 26 years old, had poor-tomoderate knowledge about HPV and were not concerned about HPV-related diseases. Over a half of MSM were willing to accept HPV vaccine, if offered. However, there was large variability in HPV vaccine acceptability, partially due to inconsistencies in methods of ascertainment but also different levels of HPV vaccine awareness. Conclusions Despite several misconceptions and poor knowledge of HPV infection, MSM might be receptive to HPV vaccination. However, further research is needed to identify which factors contribute to potential vaccine uptake in hypothetical MSM-targeted HPV vaccination. Future studies need to target those MSM with little sexual experience, who would benefit most from HPV vaccination.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Furthermore, unvaccinated adolescents have low awareness compared with their vaccinated counterparts [52]. However, among urban adolescent males, those who are homosexual are more knowledgeable about the HPV vaccine than heterosexual adolescent males [53].…”

Section: Lack Of Awareness Among Parents and Adolescentsmentioning

confidence: 98%

An update on barriers to adolescent human papillomavirus vaccination in the USA

Berenson

2015

Expert Review of Vaccines

View full text Add to dashboard Cite

Human papillomavirus is the most common sexually transmitted infection in the USA. It is the primary cause of almost all cervical cancers as well as several other cancers that affect both men and women. Adolescents of both genders can now prevent transmission of the most common oncogenic strains of human papillomavirus by obtaining a safe, three-dose vaccine series. However, despite its potential to save lives and reduce severe morbidity, many US adolescents have not been vaccinated. This is in contrast to other countries where high rates of vaccination are already reducing rates of cervical intra-epithelial neoplasia and genital warts. This article describes barriers recently reported among families in the USA and concludes with suggestions for improving uptake.

show abstract

“…[29][30][31] Unfortunately all these issues among young males have only been studied to a limited extent. [32][33][34][35][36] Specifically in Italy, few studies have been conducted among different groups, [37][38][39] but to the authors' knowledge little is known to date regarding HPV vaccination in young males. It remains imperative this evaluation in order to identify information needs and to design future strategies for expanding cancer prevention.…”

Section: Introductionmentioning

confidence: 99%

Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy

Napolitano

Liguori

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

This study assessed knowledge and attitudes about Human papillomavirus (HPV) and the relative vaccination and their determinants in a sample of young males. The survey was conducted between January and April 2015 among a sample of 1000 males aged between 14-24 y in the geographic area of Naples and Caserta, Italy. The 54.9% of the participants reported of having heard about the HPV infection. Those who were aware about the availability of the vaccine, who reported the first vaginal sexual encounter before the 18 y and at least at 18 y compared to those who had not had a complete sexual intercourse, who had undergone a health checkup in the last year, and who had received information about the HPV vaccine by physicians had a significant higher knowledge about the HPV infection. The 58.2% reported that they would be willing to receive the HPV vaccine. Those younger, who reported the first vaginal sexual encounter at least at 18 y, who agreed that male should receive the vaccine, who knew that both males and females can acquire the infection, and who agreed that the vaccine is an important preventive intervention, expressed more positive attitude toward willingness to receive the vaccine. More information about the HPV vaccine were required by those who agreed that the vaccine is an important preventive intervention, who reported the first vaginal sexual encounter at least at 18 y, who have had only one partner in the last year compared to students who had no partner, and who had received information about the vaccine by physicians. This study highlights a need for improved education of young males of the HPV infection and the associated diseases and about the benefit of the vaccination.

show abstract

Acceptability of the Human Papillomavirus Vaccine Among Urban Adolescent Males

Cited by 37 publications

References 27 publications

Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review

Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review

An update on barriers to adolescent human papillomavirus vaccination in the USA

Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy

Contact Info

Product

Resources

About